Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

S080_BrCaRes_Schneeweiss et al.


ABSTRACT: In patients with primary breast cancer, neoadjuvant chemotherapy with doxorubicin plus pemetrexed followed by docetaxel (AP-D) is associated with a pathologic complete response (pCR) rate of 16.5%, and doxorubicin plus cyclophosphamide followed by docetaxel (AC-D) is associated with a pCR rate of 20.2%. Our primary objective was to identify single predictive genetic markers for achievement of pCR following either AP-D or AC-D treatment. Our main secondary objective was to detect treatment-group specific, pCR-predictive gene signatures.

ORGANISM(S): Homo sapiens

DISEASE(S): breast adenocarcinoma

SUBMITTER: Daniel Haag 

PROVIDER: E-TABM-1186 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2010-10-01 | E-TABM-814 | biostudies-arrayexpress
2012-01-07 | E-MEXP-3450 | biostudies-arrayexpress
2007-06-14 | E-MEXP-1034 | biostudies-arrayexpress
2016-03-01 | E-GEOD-70394 | biostudies-arrayexpress
2010-06-24 | E-GEOD-17221 | biostudies-arrayexpress
2013-04-11 | E-GEOD-45957 | biostudies-arrayexpress
2023-01-25 | PXD035818 | Pride
2005-08-23 | E-EMBL-4 | biostudies-arrayexpress
2016-07-22 | E-GEOD-75007 | biostudies-arrayexpress
2013-08-29 | E-GEOD-50402 | biostudies-arrayexpress